TY - JOUR AU - Qiu, Wei AU - Wang, Xiaonan AU - Romanov, Vladimir AU - Hutchinson, Ashley AU - Lin, Andrés AU - Ruzanov, Maxim AU - Battaile, Kevin P. AU - Pai, Emil F. AU - Neel, Benjamin G. AU - Chirgadze, Nickolay Y. PY - 2014 DA - 2014/03/14 TI - Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11) JO - BMC Structural Biology SP - 10 VL - 14 IS - 1 AB - The ubiquitous non-receptor protein tyrosine phosphatase SHP2 (encoded by PTPN11) plays a key role in RAS/ERK signaling downstream of most, if not all growth factors, cytokines and integrins, although its major substrates remain controversial. Mutations in PTPN11 lead to several distinct human diseases. Germ-line PTPN11 mutations cause about 50% of Noonan Syndrome (NS), which is among the most common autosomal dominant disorders. LEOPARD Syndrome (LS) is an acronym for its major syndromic manifestations: multiple Lentigines, Electrocardiographic abnormalities, Ocular hypertelorism, Pulmonary stenosis, Abnormalities of genitalia, Retardation of growth, and sensorineural Deafness. Frequently, LS patients have hypertrophic cardiomyopathy, and they might also have an increased risk of neuroblastoma (NS) and acute myeloid leukemia (AML). Consistent with the distinct pathogenesis of NS and LS, different types of PTPN11 mutations cause these disorders. SN - 1472-6807 UR - https://doi.org/10.1186/1472-6807-14-10 DO - 10.1186/1472-6807-14-10 ID - Qiu2014 ER -